UBE2O negatively regulates TRAF6-mediated NF-κB activation by inhibiting TRAF6 polyubiquitination

Cell Research

Volumn 23, Issue 3, 2013, Pages 366-377

  Zhang, Xiaofei ^a   Zhang, Juan ^a   Zhang, Long ^a   Van Dam, Hans ^a   Ten Dijke, Peter ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

NF B signaling; polyubiquitination; TRAF6; UBE2O

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYD88 PROTEIN, HUMAN; MYELOID DIFFERENTIATION FACTOR 88; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUITIN CONJUGATING ENZYME;

ARTICLE; CELL LINE; GENETICS; HUMAN; IMMUNOBLOTTING; IMMUNOPRECIPITATION; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UBIQUITINATION;

CELL LINE; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; PROTEIN BINDING; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6; UBIQUITIN-CONJUGATING ENZYMES; UBIQUITINATION;

EID: 84874663069     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2013.21     Document Type: Article

References (33)

1. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001; 1:135-145.
2. Akira S, Takeda K. Toll-like receptor signaling. Nat Rev Immunol 2004; 4:499-511.
3. Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 1997; 7:837-847.
4. Medzhitov R, Preston-Hurlburt P, Kopp E, et al. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 1998; 2:253-258.
5. Martin MU, Wesche H. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim Biophys Acta 2002; 1592:265-280.
6. Cao Z, Henzel WJ, Gao X. IRAK: a kinase associated with the interleukin-1 receptor. Science 1996; 271:1128-1131.
7. Wesche H. IRAK-M is a novel member of the pelle/interleukin-1 receptor-associated kinase (IRAK) family. J Biol Chem 1999; 274:19403-19410.
8. Deng L, Wang C, Spencer E, et al. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 2000; 103:351-361.
9. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001; 412:346-351.
10. Takaesu G, Kishida S, Hiyama A, et al. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol Cell 2000; 5:649-658.
11. Chung JY, Park YC, Ye H, Wu H. All TRAFs are not created equal: common and distinct molecular mechanisms of TRAFmediated signal transduction. J Cell Sci 2002; 115:679-688.
12. Wu H, Arron JR. TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology. BioEssays 2003; 25:1096-1105.
13. Lomaga MA, Yeh WC, Sarosi I, et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev 1999; 13:1015-1024.
14. Xiao N, Li H, Luo J, et al. Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration. Biochem J 2012; 441:979-986.
15. Zhou F, Zhang X, van Dam H, Ten Dijke P, Huang H, Zhang L. Ubiquitin-specific protease 4 mitigates Toll-like/interleukin-1 receptor signaling and regulates innate immune activation. J Biol Chem 2012; 287:11002-11010.
16. Boone DL, Turer EE, Lee EG, et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 2004; 5:1052-1060.
17. Jin W, Chang M, Paul EM, et al. Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice. J Clin Invest 2008; 118:1858-1866.
18. Liang J, Saad Y, Lei T, et al. MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-κB signaling. J Exp Med 2010; 207:2959-2973.
19. Klemperer NS, Berleth ES, Pickart CM. A novel, arsenitesensitive E2 of the ubiquitin pathway: purification and properties. Biochemistry 1989; 28:6035-6041.
20. Bartke T, Pohl C, Pyrowolakis G, Jentsch S. Dual role of BRUCE as an antiapoptotic IAP and a chimeric E2/E3 ubiquitin ligase. Mol Cell 2004; 14:801-811.
21. Yokota T, Nagai H, Harada H, et al. Identification, tissue expression, and chromosomal position of a novel gene encoding human ubiquitin-conjugating enzyme E2-230k. Gene 2001; 267:95-100.
22. Haldeman MT, Finley D, Pickart CM. Dynamics of ubiquitin conjugation during erythroid differentiation in vitro. J Biol Chem 1995; 270:9507-9516.
23. Wefes I, Mastrandrea LD, Haldeman M, et al. Induction of ubiquitin-conjugating enzymes during terminal erythroid differentiation. Proc Natl Acad Sci USA 1995; 92:4982-4986.
24. Markson G, Kiel C, Hyde R, et al. Analysis of the human E2 ubiquitin conjugating enzyme protein interaction network. Gen Res 2009; 19:1905-1911.
25. He X, Li Y, Li C, et al. USP2a negatively regulates IL-1β-and virus-induced NF-κB activation by deubiquitinating TRAF6. J Mol Cell Biol 2012 Jul 5; 10.1093/jmcb/mjs024.
26. Munoz E, Courtois G, Veschambre P, Jalinot P, Israel A. Tax induces nuclear translocation of NF-κB through dissociation of cytoplasmic complexes containing p105 or p100 but does not induce degradation of IκBα/MAD3. J Virol 1994; 68:8035-8044.
27. Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282:2085-2088.
28. Cirl C, Wieser A, Yadav M, et al. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat Med 2008; 14:399-406.
29. Doyle SL, Husebye H, Connolly DJ, Espevik T, O'Neill LA, McGettrick AF. The GOLD domain-containing protein TMED7 inhibits TLR4 signaling from the endosome upon LPS stimulation. Nat Commun 2012; 3:707.
30. Zhu J, Smith K, Hsieh PN, et al. High-throughput screening for TLR3-IFN regulatory factor 3 signaling pathway modulators identifies several antipsychotic drugs as TLR inhibitors. J Immunol 2010; 184:5768-5776.
31. Zhang J, Zhang X, Zhang L, Zhou F, van Dinther M, Ten Dijke P. LRP8 mediates Wnt/β-catenin signaling and controls osteoblast differentiation. J Bone Miner Res 2012; 27:2065-2074.
32. Tatham MH, Rodriguez MS, Xirodimas DP, Hay RT. Detection of protein SUMOylation in vivo. Nat Protoc 2009; 4:1363-1371.
33. Shembade N, Harhaj EW. Regulation of NF-κB signaling by the A20 deubiquitinase. Cell Mol Immunol 2012; 9:123-130.